바이오인

In order to identify opportunities and challenges faced by the UK regenerative medicine community, spanning discovery, translational science and clinical delivery, four UK research councils (BBSRC, EPSRC, ESRC and MRC) and the Technology Strategy Board (TSB) have undertaken a review of the field. This identified eight key UK strategic objectives that will need to be addressed if the UK is to make the most of its current position. To be of greatest impact, advances in the field will need to be made in parallel within a framework that brings balance and coherence to the UK effort. To this end, the sponsor group has developed a coordinated and overlapping set of delivery mechanisms, spanning its area of responsibility, to meet the identified objectives.